Tyrosinehydroxylase Immunoreactive Cells In The Rat Striatum Following Treatment With

The Parkinson's-Reversing Breakthrough

Is There A Cure for Parkinson Disease

Get Instant Access

M. B. O'Byrne, 'J. P. Bolam, J. J. Hanley and K. F. Tipton

Department ofBiochemistry, Trinity College Dublin 2, Ireland

'MRC Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, UK

Abstract: Tyrosine Hydroxylase is the rate-limiting enzyme in the synthesis of dopamine, and as such, it is widely used as a marker of dopaminergic cells. Within the basal ganglia, the dopaminergic cells are located in the substantia nigra pars compacta, and project to the striatum. It is this pathway which degenerates during Parkinson's disease. The data presented here illustrate examples of tyrosine-hydroxylase immunoreactive cells in striatum following intrastriatal injection with the neurotoxin MPP+. We further show by electron microscopy that these cells are, in fact, neurons and that they possess ultrastructural features of interneurons.

Was this article helpful?

0 0

Post a comment